Loading clinical trials...
Loading clinical trials...
The primary and secondary objectives are to respectively monitor the safety and effectiveness of Spesolimab IV in Korean patients with flares with generalized pustular psoriasis (GPP) in a routine med...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT06100991 · Generalized Pustular Psoriasis
NCT06477536 · Generalized Pustular Psoriasis
NCT06323356 · Generalized Pustular Psoriasis, Erythrodermic Psoriasis
NCT07448428 · Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP)
NCT07314060 · Generalized Pustular Psoriasis
Pusan National University Yangsan Hospital
Busan
Asan Medical Center
Seoul
Samsung Medical Center
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions